Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SGLT2 inhibitors (Dapagliflozin and Empagliflozin)
DRUG
2 trials
Sponsors
October 6 University
, Samsung Medical Center
Conditions
Atrial Fibrillation
DC Cardioversion
Genetic Polymorphisms
Heart Failure
SGLT2 Inhibitor
Phase 4
Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
Recruiting
NCT07776054
Samsung Medical Center
Atrial Fibrillation, DC Cardioversion, SGLT2 Inhibitor
Start: 2024-02-01
End: 2027-09-01
Target: 200
Updated: 2026-08-20
Unknown Phase
Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients
Recruiting
NCT06201000
October 6 University
Genetic Polymorphisms, Heart Failure
Start: 2023-12-27
End: 2024-09-01
Target: 282
Updated: 2024-02-07